Literature DB >> 22004008

Post-reperfusion syndrome during isolated intestinal transplantation: outcome and predictors.

Antonio Siniscalchi1, Alessandro Cucchetti, Zuzana Miklosova, Augusto Lauro, Andrea Zanoni, Salvatore Spedicato, Enrico Bernardi, Lucia Aurini, Antonio D Pinna, Stefano Faenza.   

Abstract

BACKGROUND: Post-reperfusion syndrome (PRS) during isolated intestinal transplantation (ITx) is characterized by decreased systemic blood pressure, systemic vascular resistance, and cardiac output and by a moderate increased pulmonary arterial pressure. We hypothesize that the more severe PRS causes a poorer long-term outcome. The primary aim of this study was to determine the independent clinical predictors of intra-operative PRS, as well as to investigate the link between the severity of PRS and the intra-operative profiles and to examine the post-operative complications and their relationship with transplant outcome.
METHODS: This observational study was conducted on 27 patients undergoing isolated ITx in a single adult liver and multivisceral transplantation center. PRS was considered when the mean arterial blood pressure was 30% lower than the pre-unclamping value and lasted for at least one min within 10 min after unclamping. RESULTS AND
CONCLUSIONS: The main results of this study can be summarized in two findings: in patients undergoing ITx, the duration of cold ischemia and the pre-operative glomerular filtration rate were independent predictors of PRS and the occurrence of intra-operative PRS was associated with significantly more frequent post-operative renal failure and early post-operative death.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22004008     DOI: 10.1111/j.1399-0012.2011.01530.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  1 in total

1.  Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation.

Authors:  Xiaoliang Gan; Dandan Xing; Guangjie Su; Shun Li; Chenfang Luo; Michael G Irwin; Zhengyuan Xia; Haobo Li; Ziqing Hei
Journal:  Oxid Med Cell Longev       Date:  2015-07-12       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.